AXNX (Axonics Modulation Technologies) יחס שווי שוק לשווי בספרים

Axonics, Inc. (AXNX) specializes in bladder neurostimulators, aiming for expansion and integration into a major medtech behemoth. A narrow asset profile is offset by rapid growth in market presence. Demand for such implants remains stable and is largely crisis-resistant. The current market-to-book ratio helps assess the asset premium, while 4.51 reflects the latest metric value on the chart.

The market capitalization-to-book ratio determines the value of a single dollar of net assets in the eyes of investors. This metric is calculated as the quotient of the company's market value to its equity, reacting to any changes in financial reporting. By analyzing the shift in the market cap-to-book multiple, one can observe the current value of 4.51. A high multiple confirms the premium valuation of Axonics, Inc. (AXNX) due to the lifelong retention of patients within the neuromodulation ecosystem and the support of medtech behemoths.